<rss version="2.0" xmlns:media="http://search.yahoo.com/mrss/"><channel><title>医学新闻</title><description>来自News -Medical.net-世界各地的最新医学新闻和研究</description><link/>https://www.news-medical.net/<language> en-gb</language><item><title>资金削减了危害数十年来减少儿童死亡和死产的进步</title><description>根据联合国儿童死亡率估计机构间跨机构估算机构（UNIGME）今天发布的两份新报告，在2023年五岁之前死亡的儿童人数在2023年下降至480万，而死产的人数仍保持谦虚约为190万。</description><link/> https://www.news-medical.net/news/20250325/funding-cuts-endanger-decades-of-progress-progress-in-reducing-child-child-child-deaths-and-stillbirths.aspx<comments> https://www.news-medical.net/news/20250325/funding-cuts-endanger-decades-decades-of-progress-in-reducing-child-child-child-dephs-deaths-and-stillbirths.aspx#comment</comments><guid> https://www.news-medical.net/post.aspx?id=d94a580b-4d2222222222-4f14-89a3-7b90edc87792</guid><pubDate> Tue, 25 Mar 2025 07:49:15 -0400</pubDate> <media:content expression="full" height="480" type="image/jpeg" url="https://d2jx2rerrg6sh3.cloudfront.net/image-handler/picture/2014/6/Diet-620x480.jpg" width="620"><media:description><![CDATA[Funding cuts endanger decades of progress in reducing child deaths and stillbirths]]></media:description></media:content></item><item><title>埃里格（Elrig）宣布罗里·约翰逊（Rory Johnson）教授和沙利尼·安德森（Shalini Andersson）博士在治疗性寡核苷酸2025上担任主题演讲者</title><description>埃里格（Elrig）是一家非营利性，由志愿者领导的药物发现社区组织，今天宣布了5月14日至15日在瑞典哥德堡的阿斯利康（Astrazeneca）研发地点举行的治疗性寡核苷酸的主题演讲者。都柏林大学学院副教授罗里·约翰逊（Rory Johnson）和阿斯利康副总裁核酸疗法副总裁Shalini Andersson博士将主持今年的活动，重点是“吸毒不足”。</description><link/> https://www.news-medical.net/news/20250325/elrig-announces-prof-rory-rory-johnson-and-dr-shalini-andersson-as-keynote-speakers-speakers-therapeers-therapeast-therapeater-therapheutic-therapheutic-therapherutic-oligoncotidides-2025.aspx<comments> https://www.news-medical.net/news/20250325/elrig-announces-prof-rory-johnson-and-dr-shalini-andersson-askeynote-speakers-speakers-therapeers-attherapeer-attherpherapheutic-therapherapeutic-therapheutic-therapheutic-therapheutic-oligonuctidides-20255.aspx#comment</comments><guid> https://www.news-medical.net/post.aspx?id=41a874444444-9965-4d57-9673-21E48ED2273</guid><pubDate> Tue, 25 Mar 2025 07:44:00 -0400</pubDate> <media:content expression="full" height="480" type="image/jpeg" url="https://d2jx2rerrg6sh3.cloudfront.net/image-handler/picture/2019/5/Drug_use_and_prohibited_substances._-_Image_-_Monika_Gruszewicz_A1_b3acfd6d2daf44ecbd36979af20eb378-620x480.jpg" width="620"><media:description><![CDATA[ELRIG announces Prof Rory Johnson and Dr Shalini Andersson as keynote speakers at Therapeutic Oligonucleotides 2025]]></media:description></media:content></item><item><title> SEHTA Healthcare Business Awards认可BedFont®ScientificImimit for Innovation</title><description> Bedfont®ScientificLimited很高兴被选为2025年东南健康技术联盟（SEHTA）奖项的创新类别的决赛入围者。</description><link/> https://www.news-medical.net/news/20250325/SEHTA-Healthcare-Business-Awards-recognizes-Bedfontc2ae-Scientific-Limited-for-innovation.aspx<comments> https://www.news-medical.net/news/20250325/SEHTA-Healthcare-Business-Awards-recognizes-Bedfontc2ae-Scientific-Limited-for-innovation.aspx#comment</comments><guid> https://www.news-medical.net/post.aspx?id=0c9d67eb-1bd6-4994-4994-af9a-16caca4789d7</guid><pubDate> Tue, 25 Mar 2025 07:20:00 -0400</pubDate> <media:content expression="full" height="175" type="image/png" url="https://d2jx2rerrg6sh3.cloudfront.net/images/news/ImageForNews_805660_1742905077559245.png" width="350"><media:description><![CDATA[SEHTA Healthcare Business Awards recognizes Bedfont® Scientific Limited for innovation]]></media:description></media:content></item><item><title>许多残疾人可能会失去医疗补助，如果他们工作太多</title><description>扎克·梅切姆（Zach Mecham）听说政客要求医疗补助接收者工作或失去福利。他还遇到了一系列医疗补助规则，这些规则有效地阻止了许多残疾人从事全职工作。</description><link/> https://www.news-medical.net/news/20250325/many-people-with-with-disabilities-risk-losing-their-their-medicaid-if-if--took-work-took-too-too-too-much.aspx<comments> https://www.news-medical.net/news/20250325/many-people-with-disabilities-risk-losing-their-their-medicaid-if-if--took-work-took-too-much.aspx#comment</comments><guid> https://www.news-medical.net/post.aspx?id=39c8f6ff-5BB6-46BF-8F7E-3AC763AB1D2C</guid><pubDate> Tue, 25 Mar 2025 07:06:27 -0400</pubDate> <media:content expression="full" height="480" type="image/jpeg" url="https://d2jx2rerrg6sh3.cloudfront.net/image-handler/picture/2017/4/Accident_Injury_Information_Report_Health-Rawpixel.com_ac5524c1031e4229bc369a9a2a504d1c-620x480.jpg" width="620"><media:description><![CDATA[Many people with disabilities risk losing their Medicaid if they work too much]]></media:description></media:content></item><item><title>美国专利办公室授予GLP-1和直接口服抗凝剂（DOAC）疗法的心脏代谢能力的封闭循环医学关键专利</title><description>AI-Spable Precision药物领导者的封闭Loop Medicine Ltd.今天宣布扩大其美国专利组合。加强其心脏代谢治疗组合，该公司现在拥​​有专利，涵盖了肥胖和糖尿病的GLP-1疗法的进步，以及直接的口服抗凝剂（DOAC）（DOACS）用于心血管健康。</description><link/> https://www.news-medical.net/news/20250325/us-patent-office-office-grants-clants-claste-close-close-close-medicine-key-patents-for-cardiometimomet-cardiometabolic-capabolic-capabolic-chlp-1-in-glp-1-1----------------- eral-oral-oral-coagagulants-coagulants-coagulants-coagulants-coagulants-eptooacce-- thedoacce- asspeass.aspx.aspx.aspx<comments> https://www.news-medical.net/news/20250325/US-Patent-Office-grants-Closed-Loop-Medicine-key-patents-for-cardiometabolic-capabilities-in-GLP-1-and-Direct-Oral-Anti-Coagulants-(DOAC)-therapies.aspx#comment</comments><guid> https://www.news-medical.net/post.aspx?id=27da9bf7-220f-434c-b750-dd1adc213dad</guid><pubDate> Tue, 25 Mar 2025 06:29:00 -0400</pubDate> <media:content expression="full" height="480" type="image/jpeg" url="https://d2jx2rerrg6sh3.cloudfront.net/image-handler/picture/2014/7/Insulin-620x480.jpg" width="620"><media:description><![CDATA[US Patent Office grants Closed Loop Medicine key patents for cardiometabolic capabilities in GLP-1 and Direct Oral Anti-Coagulants (DOAC) therapies]]></media:description></media:content></item><item><title>优化纳洛酮试剂盒分布以防止阿片类药物死亡</title><description>多伦多大学工程研究人员的一项新研究指出，通过优化纳洛酮试剂盒的分布来防止阿片类药物中毒死亡的实用策略。</description><link/> https://www.news-medical.net/news/20250324/optimizing-naloxone-kit-distribution-to-prevent-opioid-deaths.aspx<comments> https://www.news-medical.net/news/20250324/optimizing-naloxone-kit-distribution-to-prevent-opioid-deaths.aspx#comment</comments><guid> https://www.news-medical.net/post.aspx?id=3c2ec62b-b1ed-4699-962a-962a-9fdb3c9382ae</guid><pubDate> Mon, 24 Mar 2025 23:26:00 -0400</pubDate> <media:content expression="full" height="480" type="image/jpeg" url="https://d2jx2rerrg6sh3.cloudfront.net/image-handler/picture/2014/7/Cardiac_Arrest-620x480.jpg" width="620"><media:description><![CDATA[Optimizing naloxone kit distribution to prevent opioid deaths]]></media:description></media:content></item><item><title>了解铁依赖性铁毒在免疫抑制中的作用</title><description>铁依赖性铁凋亡是一种非凋亡细胞死亡机制，它因其在免疫抑制中的作用而引起人们的注意。</description><link/> https://www.news-medical.net/news/20250324/understanding-the-the--role-of-rir-iron-depertent-ferroptosis-in-mmmune-suppression.aspx<comments> https://www.news-medical.net/news/20250324/understanding-the-the-the-the--role-of-rir-dipper--ferroptosis-in-roptosis-in-mmmmune-suppression.aspx#comment</comments><guid> https://www.news-medical.net/post.aspx?id=97CCDB50-F30C-4E30-8E9D-832CA8E2DC3E</guid><pubDate> Mon, 24 Mar 2025 23:22:00 -0400</pubDate> <media:content expression="full" height="480" type="image/jpeg" url="https://d2jx2rerrg6sh3.cloudfront.net/image-handler/picture/2019/6/Cancer_Cell_self_destructing_cancer_cure_treatment_T-cell_lymphocyte_killing_tum_-_CI_Photos_A1_0701d009a31c40db81f8c088e286d42a-620x480.jpg" width="620"><media:description><![CDATA[Understanding the role of iron-dependent ferroptosis in immune suppression]]></media:description></media:content></item><item><title>研究表明，Covid-19锁定后法国的门诊抗生素使用情况下降</title><description>法国的COVID-19大流行和锁定措施影响了医疗保健的获取和处方模式，从而导致门诊（卧床）抗生素的使用显着变化。</description><link/> https://www.news-medical.net/news/20250324/study-shows-decline-in-bambulatoration-randibotic-use-use-inbiotic-use-in-france-forlance-follance-following-covid-covid-19-lockdown.aspx<comments> https://www.news-medical.net/news/20250324/study-shows-nows-decline-in-bambulatoration-andbulatory-antbulatoric-use-use-in-france-forclance-follance-following-covid-covid-19-lockdown.aspx#comment</comments><guid> https://www.news-medical.net/post.aspx?id=259572F6-4874-4D72-9DAA-A37B9BE2562B</guid><pubDate> Mon, 24 Mar 2025 23:18:53 -0400</pubDate> <media:content expression="full" height="480" type="image/jpeg" url="https://d2jx2rerrg6sh3.cloudfront.net/image-handler/picture/2014/7/pill_antibiotics-620x480.jpg" width="620"><media:description><![CDATA[Study shows decline in ambulatory antibiotic use in France following COVID-19 lockdown]]></media:description></media:content></item><item><title>高性能诊所共享有效的慢性护理随访策略</title><description>定期的随访访问对于管理慢性病至关重要，但是一些初级保健诊所比其他诊所获得了更高的访问规律性。</description><link/> https://www.news-medical.net/news/20250324/high-performing-clinics-share-efferce--strategies-for-chronic-care-care-follow-pollow-pollow-aspx<comments> https://www.news-medical.net/news/20250324/high-performing-clinics-share-meffactive-strategies-for-chronic-care-care-care-follow-up-aspx#comment</comments><guid> https://www.news-medical.net/post.aspx?id=3c4472d8-5627-4ff7-4ff7-aa58-50bbb3ac4d4ed</guid><pubDate> Mon, 24 Mar 2025 23:14:35 -0400</pubDate></item><item><title>治疗衣原体和淋病在初级保健中发现的差异</title><description>确认诊断后迅速治疗衣原体和淋病治疗对于防止并发症和减少传播至关重要。在初级保健环境中遵守疾病控制中心（CDC）治疗指南仍然是一个问题。</description><link/> https://www.news-medical.net/news/20250324/disparities-dissparities-indise--in-woreatment-of-chlamydia-and-gonarrhea-in-rimary-care.aspx<comments> https://www.news-medical.net/news/20250324/disparities-dissparities-indise-in-woreatment-of-chlamydia-and-gonarrhea-in-rimary-care.aspx#comment</comments><guid> https://www.news-medical.net/post.aspx?id=419824B8-C50E-43F6-9D69-9978E19254EB</guid><pubDate> Mon, 24 Mar 2025 23:11:42 -0400</pubDate> <media:content expression="full" height="480" type="image/jpeg" url="https://d2jx2rerrg6sh3.cloudfront.net/image-handler/picture/2014/7/Neisseria_gonorrhoeae-620x480.jpg" width="620"><media:description><![CDATA[Disparities identified in treatment of chlamydia and gonorrhea in primary care]]></media:description></media:content></item></channel></rss>